SynthesisKardiologia polska2018

Patients treated with bivalirudin are still at higher risk of stent thrombosis: a comprehensive meta-analysis of randomised clinical trials of bivalirudin and heparin for percutaneous coronary interventions.

Stefan Grajek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.